Category: Press Release - Page 123 - Psychedelic Alpha

Part 3 of our Year in Review video series is out now.

Read more about the article MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs

Post published:June 10, 2021
Post category:Press Release

Read more about the article MindMed Announces Chief Executive Officer Transition

MindMed Announces Chief Executive Officer Transition

Post published:June 9, 2021
Post category:Press Release

Read more about the article Filament Cultivates 20th Psychedelic Mushroom Variety and Provides Propagation Update

Filament Cultivates 20th Psychedelic Mushroom Variety and Provides Propagation Update

Post published:June 9, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Completes Previously Announced Private Placement For Gross Proceeds Of $8.3 Million

Awakn Life Sciences Completes Previously Announced Private Placement For Gross Proceeds Of $8.3 Million

Post published:June 8, 2021
Post category:Press Release

Read more about the article Red Light Holland Closes Acquisition of Cutting Edge Silicon Valley Applied Sciences Company Radix Motion, Becoming a Leader in Psychedelic Technology

Red Light Holland Closes Acquisition of Cutting Edge Silicon Valley Applied Sciences Company Radix Motion, Becoming a Leader in Psychedelic Technology

Post published:June 8, 2021
Post category:Press Release

Read more about the article Silo Pharma Announces Collaboration with University California San Francisco to study Psilocybin as an Anti-Inflammatory agent in Parkinson’s and Bipolar Patients

Silo Pharma Announces Collaboration with University California San Francisco to study Psilocybin as an Anti-Inflammatory agent in Parkinson’s and Bipolar Patients

Post published:June 8, 2021
Post category:Press Release

Read more about the article The Psyence Group Announces its Formal Entry into Jamaica with the Incorporation of its Wholly Owned Subsidiary, Psyence Jamaica Limited

The Psyence Group Announces its Formal Entry into Jamaica with the Incorporation of its Wholly Owned Subsidiary, Psyence Jamaica Limited

Post published:June 8, 2021
Post category:Press Release

Read more about the article Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Post published:June 8, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market

Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market

Post published:June 8, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

Post published:June 4, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.